NCT02721732 2026-01-29Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are MetastaticM.D. Anderson Cancer CenterPhase 2 Active not recruiting157 enrolled 26 charts
NCT03647163 2025-09-16Ph I/II Trial of Systemic VSV-IFNβ-NIS in Combination With Checkpoint Inhibitor Therapy in Patients With Select Solid TumorsVyriad, Inc.Phase 1/2 Active not recruiting33 enrolled